These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10335663)

  • 21. Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1.
    Krachmarov CP; Honnen WJ; Kayman SC; Gorny MK; Zolla-Pazner S; Pinter A
    J Virol; 2006 Jul; 80(14):7127-35. PubMed ID: 16809318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.
    Cham F; Zhang PF; Heyndrickx L; Bouma P; Zhong P; Katinger H; Robinson J; van der Groen G; Quinnan GV
    Virology; 2006 Mar; 347(1):36-51. PubMed ID: 16378633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sequence variation in the env V3-V4 region of HIV type 1 predominant subtype B and C strains circulating in China].
    Liang H; Wei M; Chen Z; Xing H; Zhao QB; Feng Y; Guan Q; Shi LY; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):153-8. PubMed ID: 12869999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.
    Ferris RL; Hall C; Sipsas NV; Safrit JT; Trocha A; Koup RA; Johnson RP; Siliciano RF
    J Immunol; 1999 Feb; 162(3):1324-32. PubMed ID: 9973386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
    Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diversity of the HIV-1 long terminal repeat following mother-to-child transmission.
    Blackard JT; Renjifo B; Chaplin B; Msamanga G; Fawzi W; Essex M
    Virology; 2000 Sep; 274(2):402-11. PubMed ID: 10964782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune responses and HIV: a little order from the chaos.
    O'Connor DH; Burton DR
    J Exp Med; 2006 Mar; 203(3):501-3. PubMed ID: 16533889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ancestral and consensus envelope immunogens for HIV-1 subtype C.
    Kothe DL; Li Y; Decker JM; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Weng Z; Weaver EA; Gao F; Haynes BF; Shaw GM; Korber BT; Hahn BH
    Virology; 2006 Sep; 352(2):438-49. PubMed ID: 16780913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic diversity of HIV-1 non-B strains in Sicily: evidence of intersubtype recombinants by sequence analysis of gag, pol, and env genes.
    Tramuto F; Bonura F; Perna AM; Mancuso S; Firenze A; Romano N; Vitale F;
    AIDS Res Hum Retroviruses; 2007 Sep; 23(9):1131-8. PubMed ID: 17919109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA
    Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.
    Gao F; Weaver EA; Lu Z; Li Y; Liao HX; Ma B; Alam SM; Scearce RM; Sutherland LL; Yu JS; Decker JM; Shaw GM; Montefiori DC; Korber BT; Hahn BH; Haynes BF
    J Virol; 2005 Jan; 79(2):1154-63. PubMed ID: 15613343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linkage disequilibrium test implies a large effective population number for HIV in vivo.
    Rouzine IM; Coffin JM
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10758-63. PubMed ID: 10485899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for negative selective pressure in HIV-2 evolution in vivo.
    Barroso H; Taveira N
    Infect Genet Evol; 2005 Apr; 5(3):239-46. PubMed ID: 15737915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
    Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV type 1 gag D/env G recombinants in Russia.
    Bobkov A; Kazennova E; Selimova L; Ladnaya N; Kravchenko A; Foley B; Morrison I; Pokrovsky V; Weber J; Cheingsong-Popov R
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1597-9. PubMed ID: 9840293
    [No Abstract]   [Full Text] [Related]  

  • 37. Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.
    Ye L; Bu Z; Vzorov A; Taylor D; Compans RW; Yang C
    J Virol; 2004 Dec; 78(24):13409-19. PubMed ID: 15564451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
    Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
    J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
    Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
    J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct interaction between the envelope and matrix proteins of HIV-1.
    Cosson P
    EMBO J; 1996 Nov; 15(21):5783-8. PubMed ID: 8918455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.